Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection

被引:98
作者
Horton, Helen
Frank, Ian
Baydo, Ruth
Jalbert, Emilie
Penn, Justin
Wilson, Sean
McNevin, John P.
McSweyn, Matthew D.
Lee, Deborah
Huang, Yunda
De Rosa, Stephen C.
McElrath, M. Juliana
机构
[1] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[4] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA
关键词
D O I
10.4049/jimmunol.177.10.7406
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1-infected persons with HLA-B27 and -B57 alleles commonly remain healthy for decades without antiretroviral therapy. Properties of CD8(+) T cells restricted by these alleles considered to confer disease protection in these individuals are elusive but important to understand and potentially elicit by vaccination. To address this, we compared CD8(+) T cell function induced by HIV-1 immunogens and natural infection using polychromatic flow cytometry. HIV-1-specific CD8(+) T cells from all four uninfected immunized and 21 infected subjects secreted IFN-gamma and TNF-alpha. However, CD8(+) T cells induced by vaccination and primary infection, but not chronic infection, proliferated to their cognate epitopes. Notably, B27- and B57-restricted CD8(+) T cells from nonprogressors exhibited greater expansion than those restricted by other alleles. Hence, CD8(+) T cells restricted by certain protective alleles can resist replicative defects, which permits expansion and antiviral effector activities. Our findings suggest that the capacity to maintain CD8(+) T cell proliferation, regardless of MHC-restriction, may serve as an important correlate of disease protection in the event of infection following vaccination.
引用
收藏
页码:7406 / 7415
页数:10
相关论文
共 31 条
[11]   Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS [J].
Goulder, PJR ;
Phillips, RE ;
Colbert, RA ;
McAdam, S ;
Ogg, G ;
Nowak, MA ;
Giangrande, P ;
Luzzi, G ;
Morgan, B ;
Edwards, A ;
McMichael, AJ ;
RowlandJones, S .
NATURE MEDICINE, 1997, 3 (02) :212-217
[12]   Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection [J].
Harrer, T ;
Harrer, E ;
Kalams, SA ;
Elbeik, T ;
Staprans, SI ;
Feinberg, MB ;
Cao, YZ ;
Ho, DD ;
Yilma, T ;
Caliendo, AM ;
Johnson, RP ;
Buchbinder, SP ;
Walker, BD .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (07) :585-592
[13]  
Harrer T, 1996, J IMMUNOL, V156, P2616
[14]  
Hendel H, 1999, J IMMUNOL, V162, P6942
[15]   Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques [J].
Jin, X ;
Bauer, DE ;
Tuttleton, SE ;
Lewin, S ;
Gettie, A ;
Blanchard, J ;
Irwin, CE ;
Safrit, JT ;
Mittler, J ;
Weinberger, L ;
Kostrikis, LG ;
Zhang, LQ ;
Perelson, AS ;
Ho, DD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06) :991-998
[16]   Molecular and functional profiling of memory CD8 T cell differentiation [J].
Kaech, SM ;
Hemby, S ;
Kersh, E ;
Ahmed, R .
CELL, 2002, 111 (06) :837-851
[17]   Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection [J].
Kaslow, RA ;
Carrington, M ;
Apple, R ;
Park, L ;
Munoz, A ;
Saah, AJ ;
Goedert, JJ ;
Winkler, C ;
OBrien, SJ ;
Rinaldo, C ;
Detels, R ;
Blattner, W ;
Phair, J ;
Erlich, H ;
Mann, DL .
NATURE MEDICINE, 1996, 2 (04) :405-411
[18]   Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells [J].
Lichterfeld, M ;
Kaufmann, DE ;
Yu, XG ;
Mui, SK ;
Addo, MM ;
Johnston, MN ;
Cohen, D ;
Robbins, GK ;
Pae, E ;
Alter, G ;
Wurcel, A ;
Stone, D ;
Rosenberg, ES ;
Walker, BD ;
Altfeld, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (06) :701-712
[19]   Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection [J].
Malhotra, U ;
Berrey, MM ;
Huang, YJ ;
Markee, J ;
Brown, DJ ;
Ap, S ;
Musey, L ;
Schacker, T ;
Corey, L ;
McElrath, MJ .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :121-131
[20]   Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source [J].
McKiernan, SM ;
Hagan, R ;
Curry, M ;
McDonald, GSA ;
Kelly, A ;
Nolan, N ;
Walsh, A ;
Hegarty, J ;
Lawlor, E ;
Kelleher, D .
HEPATOLOGY, 2004, 40 (01) :108-114